Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308336329> ?p ?o ?g. }
- W4308336329 endingPage "3482" @default.
- W4308336329 startingPage "3482" @default.
- W4308336329 abstract "Pancreatic cancer is a leading cause of cancer mortality and is projected to become the second-most common cause of cancer mortality in the next decade. While gene-wide association studies and next generation sequencing analyses have identified molecular patterns and transcriptome profiles with prognostic relevance, therapeutic opportunities remain limited. Among the genes that are upregulated in pancreatic ductal adenocarcinomas (PDAC), the leukaemia inhibitory factor (LIF), a cytokine belonging to IL-6 family, has emerged as potential therapeutic candidate. LIF is aberrantly secreted by tumour cells and promotes tumour progression in pancreatic and other solid tumours through aberrant activation of the LIF receptor (LIFR) and downstream signalling that involves the JAK1/STAT3 pathway. Since there are no LIFR antagonists available for clinical use, we developed an in silico strategy to identify potential LIFR antagonists and drug repositioning with regard to LIFR antagonists. The results of these studies allowed the identification of mifepristone, a progesterone/glucocorticoid antagonist, clinically used in medical abortion, as a potent LIFR antagonist. Computational studies revealed that mifepristone binding partially overlapped the LIFR binding site. LIF and LIFR are expressed by human PDAC tissues and PDAC cell lines, including MIA-PaCa-2 and PANC-1 cells. Exposure of these cell lines to mifepristone reverses cell proliferation, migration and epithelial mesenchymal transition induced by LIF in a concentration-dependent manner. Mifepristone inhibits LIFR signalling and reverses STAT3 phosphorylation induced by LIF. Together, these data support the repositioning of mifepristone as a potential therapeutic agent in the treatment of PDAC." @default.
- W4308336329 created "2022-11-11" @default.
- W4308336329 creator A5000816582 @default.
- W4308336329 creator A5016318817 @default.
- W4308336329 creator A5018930736 @default.
- W4308336329 creator A5031806192 @default.
- W4308336329 creator A5033525624 @default.
- W4308336329 creator A5037630349 @default.
- W4308336329 creator A5038809461 @default.
- W4308336329 creator A5040613191 @default.
- W4308336329 creator A5053616013 @default.
- W4308336329 creator A5057095436 @default.
- W4308336329 creator A5057720130 @default.
- W4308336329 creator A5059986730 @default.
- W4308336329 creator A5065286832 @default.
- W4308336329 creator A5065995030 @default.
- W4308336329 creator A5070852671 @default.
- W4308336329 creator A5071291514 @default.
- W4308336329 creator A5086947006 @default.
- W4308336329 date "2022-11-03" @default.
- W4308336329 modified "2023-10-18" @default.
- W4308336329 title "Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma" @default.
- W4308336329 cites W1542809057 @default.
- W4308336329 cites W1557020267 @default.
- W4308336329 cites W1824670638 @default.
- W4308336329 cites W1968812902 @default.
- W4308336329 cites W1976161355 @default.
- W4308336329 cites W1976499671 @default.
- W4308336329 cites W1979401635 @default.
- W4308336329 cites W1985648424 @default.
- W4308336329 cites W1993515289 @default.
- W4308336329 cites W2000465781 @default.
- W4308336329 cites W2013122898 @default.
- W4308336329 cites W2014139160 @default.
- W4308336329 cites W2015688756 @default.
- W4308336329 cites W2029667189 @default.
- W4308336329 cites W2039225116 @default.
- W4308336329 cites W2042844479 @default.
- W4308336329 cites W2055225975 @default.
- W4308336329 cites W2078569496 @default.
- W4308336329 cites W2085636773 @default.
- W4308336329 cites W2092016723 @default.
- W4308336329 cites W2094111001 @default.
- W4308336329 cites W2095719702 @default.
- W4308336329 cites W2119174526 @default.
- W4308336329 cites W2135802413 @default.
- W4308336329 cites W2153327715 @default.
- W4308336329 cites W2158834319 @default.
- W4308336329 cites W2167223040 @default.
- W4308336329 cites W2201282822 @default.
- W4308336329 cites W2332712348 @default.
- W4308336329 cites W2404280981 @default.
- W4308336329 cites W2409321676 @default.
- W4308336329 cites W2412534268 @default.
- W4308336329 cites W2516690438 @default.
- W4308336329 cites W2525043723 @default.
- W4308336329 cites W27140539 @default.
- W4308336329 cites W2781525129 @default.
- W4308336329 cites W2807581229 @default.
- W4308336329 cites W2885591256 @default.
- W4308336329 cites W2889646458 @default.
- W4308336329 cites W2891791233 @default.
- W4308336329 cites W2903623792 @default.
- W4308336329 cites W2936366750 @default.
- W4308336329 cites W2947010413 @default.
- W4308336329 cites W2976186080 @default.
- W4308336329 cites W3044912018 @default.
- W4308336329 cites W3080433061 @default.
- W4308336329 cites W3086801715 @default.
- W4308336329 cites W3090693089 @default.
- W4308336329 cites W3112261524 @default.
- W4308336329 cites W3121138383 @default.
- W4308336329 cites W3133335893 @default.
- W4308336329 cites W3152743508 @default.
- W4308336329 cites W3157042924 @default.
- W4308336329 cites W3188266412 @default.
- W4308336329 cites W3197559541 @default.
- W4308336329 cites W4213029009 @default.
- W4308336329 cites W4223640931 @default.
- W4308336329 cites W4224222755 @default.
- W4308336329 cites W4283749139 @default.
- W4308336329 doi "https://doi.org/10.3390/cells11213482" @default.
- W4308336329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36359879" @default.
- W4308336329 hasPublicationYear "2022" @default.
- W4308336329 type Work @default.
- W4308336329 citedByCount "3" @default.
- W4308336329 countsByYear W43083363292023 @default.
- W4308336329 crossrefType "journal-article" @default.
- W4308336329 hasAuthorship W4308336329A5000816582 @default.
- W4308336329 hasAuthorship W4308336329A5016318817 @default.
- W4308336329 hasAuthorship W4308336329A5018930736 @default.
- W4308336329 hasAuthorship W4308336329A5031806192 @default.
- W4308336329 hasAuthorship W4308336329A5033525624 @default.
- W4308336329 hasAuthorship W4308336329A5037630349 @default.
- W4308336329 hasAuthorship W4308336329A5038809461 @default.
- W4308336329 hasAuthorship W4308336329A5040613191 @default.
- W4308336329 hasAuthorship W4308336329A5053616013 @default.
- W4308336329 hasAuthorship W4308336329A5057095436 @default.